1. Anti capsid drugs HAP12 and AT130 target HBV core protein nuclear functions. (15th February 2015) Authors: Belloni, L.; Palumbo, G.A.; Li, L.; Chirapu, S.R.; Calvo, L.; Lupacchini, L.; Finn, M.G.; Lopatin, U.; Zlotnick, A.; Levrero, M. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗